Extract

The aim of this prospective study is to assess the prognostic value of bioactive plasma adrenomedullin (ADM) in 600 patients with severe sepsis or septic shock in an international multicenter study and to validate the findings concerning the association of ADM concentration and the use of vasopressor therapy, organ failure and outcome.

Inclusion criteria

• Severe sepsis ,Septic shock

Country

• Belgium
• France
• Germany
• Italy
• Netherlands

Links

• ictrp
• nct